Insulet Valuation
| PODD Stock | USD 303.15 1.36 0.45% |
At this time, the firm appears to be undervalued. Insulet retains a regular Real Value of $337.04 per share. The prevalent price of the firm is $303.15. Our model calculates the value of Insulet from evaluating the firm fundamentals such as Return On Asset of 0.0694, current valuation of 21.8 B, and Return On Equity of 0.38 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Insulet's valuation include:
Price Book 15.9604 | Enterprise Value | Enterprise Value Ebitda 51.7589 | Price Sales 9.7022 | Forward PE 73.5294 |
Undervalued
Today
Please note that Insulet's price fluctuation is very steady at this time. Calculation of the real value of Insulet is based on 3 months time horizon. Increasing Insulet's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Insulet stock is determined by what a typical buyer is willing to pay for full or partial control of Insulet. Since Insulet is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Insulet Stock. However, Insulet's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 303.15 | Real 337.04 | Target 328.73 | Hype 301.49 |
The real value of Insulet Stock, also known as its intrinsic value, is the underlying worth of Insulet Company, which is reflected in its stock price. It is based on Insulet's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Insulet's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Insulet helps investors to forecast how Insulet stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Insulet more accurately as focusing exclusively on Insulet's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Insulet's intrinsic value based on its ongoing forecasts of Insulet's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Insulet's closest peers. If more than one evaluation category is relevant for Insulet we suggest using both methods to arrive at a better estimate.
Insulet Cash |
|
Insulet Valuation Trend
Comparing Insulet's enterprise value against its market capitalization is a good way to estimate the value of Insulet uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Insulet Revenue by Product
Insulet Total Value Analysis
Insulet is at this time forecasted to have valuation of 21.8 B with market capitalization of 21.33 B, debt of 1.39 B, and cash on hands of 708.6 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Insulet fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
21.8 B | 21.33 B | 1.39 B | 708.6 M |
Insulet Investor Information
About 100.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 5.55. Insulet had not issued any dividends in recent years. Based on the key indicators related to Insulet's liquidity, profitability, solvency, and operating efficiency, Insulet is performing exceptionally good at this time. It has a great probability to report excellent financial results in July.Insulet Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Insulet has an asset utilization ratio of 67.09 percent. This indicates that the Company is making $0.67 for each dollar of assets. An increasing asset utilization means that Insulet is more efficient with each dollar of assets it utilizes for everyday operations.Insulet Ownership Allocation
The majority of Insulet outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Insulet to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Insulet. Please pay attention to any change in the institutional holdings of Insulet as this could imply that something significant has changed or is about to change at the company. On April 18, 2024, Senator Tina Smith of US Senate acquired $50k to $100k worth of Insulet's common stock.Insulet Profitability Analysis
The company reported the previous year's revenue of 2.07 B. Net Income was 418.3 M with profit before overhead, payroll, taxes, and interest of 1.55 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Insulet's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Insulet and how it compares across the competition.
About Insulet Valuation
The stock valuation mechanism determines Insulet's current worth on a weekly basis. Our valuation model uses a comparative analysis of Insulet. We calculate exposure to Insulet's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Insulet's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.4 B | 1.5 B | |
| Pretax Profit Margin | 0.14 | 0.15 | |
| Operating Profit Margin | 0.15 | 0.16 | |
| Net Profit Margin | 0.20 | 0.21 | |
| Gross Profit Margin | 0.70 | 0.73 |
Insulet Growth Indicators
Investing in growth stocks can be very risky. If the company such as Insulet does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 73.9 M | |
| Quarterly Earnings Growth Y O Y | -0.316 | |
| Forward Price Earnings | 73.5294 |
Insulet Current Valuation Indicators
Valuation refers to the process of determining the present value of Insulet and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Insulet we look at many different elements of the entity such as Insulet's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Insulet, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Insulet's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Insulet's worth.Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |